Telehealth Anxiety Prescribing: What PMHNPs Can Do in New York

You’re a psychiatrist or PMHNP considering telehealth, and the question keeps coming up: Can I really prescribe anxiety medications—including controlled substances like benzodiazepines—through video visits?

Short answer: Yes. As of 2026, both psychiatrists and psychiatric nurse practitioners can prescribe the full range of anxiety medications via telehealth, including controlled substances. But the details matter—especially around state scope-of-practice rules, federal prescribing flexibilities, and how reimbursement actually works.

If you’re evaluating whether to join a telepsychiatry platform or expand your virtual practice, understanding these rules isn’t just about compliance—it’s about knowing what patient populations you can serve, what medications you can manage remotely, and how your authority compares across state lines.

Let’s break down what you need to know.

Federal Telehealth Prescribing Rules: The Ryan Haight Waiver Extended Through 2026

Historically, the Ryan Haight Act required an in-person medical evaluation before any provider could prescribe controlled substances (like benzodiazepines or stimulants). That created a major barrier to telehealth psychiatric care—especially for anxiety patients who often need medications like alprazolam (Xanax), clonazepam (Klonopin), or lorazepam (Ativan).

COVID changed everything. In March 2020, the DEA suspended the Ryan Haight in-person requirement, allowing providers to prescribe controlled substances via telehealth without ever seeing the patient face-to-face. That flexibility was set to expire multiple times—but as of January 2, 2026, HHS and the DEA extended these telemedicine flexibilities through December 31, 2026.

What This Means for You

• You can initiate Schedule IV benzodiazepines (Xanax, Ativan, Klonopin) via video visit for new anxiety patients
• You can prescribe Schedule II stimulants (for comorbid ADHD or treatment-resistant cases) through telehealth
• You can manage ongoing medication refills for anxiety without requiring periodic in-person visits
• In 2024 alone, over 7 million controlled substance prescriptions were written via telemedicine under these rules

The catch: This is still a temporary extension. The DEA is working on permanent telemedicine prescribing regulations expected by late 2026, which may introduce new requirements—possibly a special telemedicine prescribing registration or some modified exam standards. For now, the path is clear through the end of 2026.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

State-by-State Rules: Where Your Authority Actually Comes From

Federal law sets the floor, but state law determines your scope—and there’s massive variation depending on whether you’re a psychiatrist (MD/DO) or a psychiatric mental health nurse practitioner (PMHNP).

Psychiatrists (MD/DO): Maximum Authority, Minimal Restrictions

If you’re a psychiatrist, you have full independent prescribing authority in every state. No supervision requirements. No collaborative agreements. No medication formularies limiting what you can prescribe.

The only state-level rules you need to follow:

1. PDMP checks: Every state requires you to query the Prescription Drug Monitoring Program before prescribing controlled substances (and often periodically for ongoing patients)
2. Standard of care: Document your clinical rationale, patient evaluation, and treatment plan as you would for in-person care
3. State-specific telehealth provisions: A few states have carved out exceptions or additional requirements

Key State Examples:

Florida explicitly permits telehealth prescribing of Schedule II controlled substances for psychiatric disorders—meaning you can manage anxiety (and comorbid conditions like ADHD) entirely virtually. The catch: if you’re practicing via Florida’s out-of-state telehealth registration (not a full FL license), you cannot prescribe controlled substances remotely.

Texas prohibits telemedicine treatment of chronic pain with controlled substances, but anxiety treatment doesn’t fall under that restriction. You can prescribe benzodiazepines or other anxiolytics via telehealth as long as you’ve established a proper patient-provider relationship through live video.

California, New York, Pennsylvania, Illinois: No state-level barriers beyond standard medical practice requirements. Follow federal rules, check the PDMP, document appropriately.

Bottom line for MDs: Your telehealth prescribing authority for anxiety is effectively equivalent to in-person care. The bigger question is whether you’re licensed in the states where your patients are located.

PMHNPs: Authority Depends on Your State (and Experience Level)

For psychiatric nurse practitioners, it’s more complicated. Your prescribing authority hinges on whether your state grants Full Practice Authority (FPA), requires physician collaboration, or operates somewhere in between.

Full Practice Authority States (No Physician Oversight Needed)

In FPA states, PMHNPs can evaluate, diagnose, and prescribe all anxiety medications—including controlled substances—independently. Your scope is functionally equivalent to a psychiatrist’s.

New York (as of 2022): Full independence. No collaborative agreement required. No physician sign-off on prescriptions. You can open your own practice managing anxiety patients via telehealth with zero physician involvement.

Oregon, Washington, Arizona, Alaska and about 20 other states: Similar full practice authority for experienced PMHNPs.

Collaborative Agreement States (Physician Oversight Required)

Most states still require PMHNPs to maintain a formal relationship with a physician to prescribe.

Texas: You must have a Prescriptive Authority Agreement with a supervising physician. The physician doesn’t co-sign every prescription, but they must be available for consultation and conduct periodic chart reviews.

Critical limitation in Texas: NPs can only prescribe Schedule II controlled substances (like Adderall) in hospital settings or for hospice patients. For outpatient anxiety management, you’re limited to Schedule IV benzos and below—which covers most anxiety meds, but matters if you’re treating comorbid ADHD.

Florida: Requires a written protocol with a physician. However, psychiatric NPs get an exemption from Florida’s 7-day limit on controlled substance prescriptions when treating mental health conditions—meaning you can prescribe more than a week’s supply of Xanax or similar meds for anxiety, unlike NPs in other specialties.

Pennsylvania: Mandatory collaborative agreement. Physicians must countersign a percentage of your charts (up to 100% for Schedule II prescriptions). No pathway to independence regardless of experience.

Transitional States (Earn Independence Through Experience)

California (AB 890): New grads need physician supervision, but NPs with 3+ years of experience can become ‘103 NPs’ (limited independence in group settings) or ‘104 NPs’ (full solo practice, available starting 2026). If you qualified in 2023-2024, you can now practice independently managing anxiety via telehealth.

Illinois: Requires collaboration initially, but after 4,000 clinical hours + 250 CE hours, you can apply for Full Practice Authority. Even then, you need a one-time physician attestation to prescribe benzodiazepines or Schedule II meds—essentially a sign-off that it’s within your scope.

PMHNP vs MD: The Real-World Impact

For anxiety treatment specifically, the gap between PMHNP and psychiatrist authority matters most in:

1. Controlled substance prescribing: In restricted states, you may not be able to initiate benzos without physician approval, even if it’s clinically appropriate
2. Telehealth platform participation: Some platforms require PMHNPs to have on-staff physician collaborators in states without FPA, adding overhead
3. Patient perception: Some patients (and referral sources) still assume only psychiatrists can prescribe certain medications, though that’s increasingly outdated

Reimbursement: What You’ll Actually Get Paid for Virtual Anxiety Care

Understanding reimbursement rates matters whether you’re evaluating a platform offer or deciding which insurance panels to join.

Medicare Rates (2026 Fee Schedule)

Medicare pays well for psychiatric medication management—often better than other specialties for similar time spent:

• Initial psychiatric evaluation (90792): ~$202
• 15-minute med check follow-up (99213): ~$95
• 25-minute moderate complexity visit (99214): ~$136
• 30-minute psychotherapy add-on (90833): ~$81

Telehealth parity: Medicare currently pays the same rate for virtual visits as in-person through at least 2026, thanks to ongoing legislative extensions.

One important caveat: Medicare had planned to require tele-mental health patients to have an in-person visit within 6 months (and annually thereafter), but Congress keeps delaying enforcement. As of early 2026, you can still see Medicare patients entirely via telehealth for anxiety management—but watch for rule changes if the in-person requirement eventually takes effect.

Medicaid Rates (State-Dependent, Typically Lower)

Medicaid reimburses at roughly 50-60% of Medicare rates:

• 90792 (initial eval): ~$85 (vs $202 Medicare)
• 99213 (med check): ~$40-50 (vs $95 Medicare)

The volume can be high—many anxiety patients are on Medicaid—but the per-visit economics are tougher. Most states now require Medicaid plans to cover telehealth at the same rate as in-person, which helps.

Commercial Insurance

Private insurers typically pay 100-150% of Medicare rates, depending on your contract and region. A 99213 med check might bring $100-$130 through a commercial plan.

Telehealth parity laws in states like California (AB 744), Illinois, and New York require private insurers to reimburse virtual psychiatric care at the same rate as in-person. Texas has no parity mandate, but many insurers voluntarily pay equally for tele-mental health.

PMHNP Reimbursement: The 85% Rule

If you’re a PMHNP billing under your own NPI, Medicare and most insurers reimburse at 85% of the physician rate for the same service. So where a psychiatrist gets $100 for a med check, you’d get $85.

Some practices use ‘incident to’ billing (where the NP’s service is billed under a supervising physician’s NPI at 100% rate), but that’s difficult in telepsychiatry and requires the physician to be closely involved in care.

Platform implications: Telepsychiatry companies factor this into their pay models. Some pay NPs and MDs the same per-visit rate (absorbing the insurance difference). Others adjust NP pay to reflect the lower reimbursement, though this is often offset by lower NP salary expectations.

The Economics of Patient Acquisition: Why Platforms Make Sense

Here’s where provider marketing gets real: acquiring psychiatric patients on your own is expensive and time-consuming.

The True Cost of DIY Patient Acquisition

Let’s say you want to build a cash-pay or insurance-based telehealth practice for anxiety treatment. You’ll need patients, which means marketing:

SEO (search engine optimization): Effective, but takes 6-12 months of consistent content creation, website optimization, and backlink building before you see meaningful patient flow. You’ll likely need an agency ($2,000-5,000/month) or spend hours doing it yourself. ROI is uncertain.

Google Ads: Mental health keywords are expensive—$15-40+ per click. Most clicks don’t convert to booked appointments. By the time you account for ad spend, landing page optimization, lead qualification, and no-shows from cold leads, your cost per booked patient is often $200-400+.

Directory listings (Psychology Today, Zocdoc): You pay monthly fees ($30-50+) to list your profile, then compete with hundreds of other providers on the same page. Zocdoc charges per booking ($35-100+ per new patient lead), and you still need to convert them. Total monthly costs for multiple directories add up fast.

Paid social media: Can work for building a brand, but converting Facebook or Instagram followers into paying anxiety patients requires sophisticated funnels and ongoing ad spend.

Reality check: Most solo providers spend $3,000-5,000/month on marketing with uncertain results, especially in the first 6-12 months. That’s $36,000-60,000 per year in upfront costs before you know if it’s working.

How Platforms Like Klarity Change the Economics

Telehealth platforms flip the model: instead of paying upfront for marketing with no guarantee of patients, you pay per booked appointment—essentially a finder’s fee for pre-qualified leads.

Klarity’s model (and similar platforms):

• No upfront marketing spend
• No monthly subscription fees
• You pay a standard listing fee when a patient books with you (similar to how Zocdoc charges per booking, but without the separate monthly platform fee)
• Patients are already screened and matched to your specialty and availability
• Built-in telehealth infrastructure (no separate EHR or video platform costs)
• Both insurance and cash-pay patient flow

The key value: You only pay when you actually see a patient. There’s no wasted spend on clicks that don’t convert, no months of SEO investment before any results, no paying for directory listings that generate zero leads.

The Math Makes Sense

Let’s compare:

DIY marketing: $4,000/month marketing spend. Maybe you get 10 new anxiety patients in month 3 (after ramping up). That’s $400 per patient acquisition cost, and you’ve spent $12,000 total in the first 3 months to get there.

Platform model: You join Klarity, set your availability, and start seeing patients in week 1. You pay a per-appointment fee for each new patient (let’s say comparable to Zocdoc’s $35-100 range, though actual platform fees vary). But you’re not gambling $4,000/month hoping for results—you pay only when patients actually book.

Better ROI: Instead of risking thousands on marketing channels that may not work, you get guaranteed patient flow in exchange for a per-appointment fee. That fee is your patient acquisition cost—transparent, predictable, and you only pay for actual patients.

State-Specific Prescribing Nuances You Should Know

California

• NP independence timeline: If you graduated before 2020 and have 3 years experience, you can apply for 103 NP status now (limited independence). Full independence (104 NP) available starting 2026.
• No state telehealth restrictions on controlled substances beyond federal rules
• Not part of IMLC for physicians (must get full CA license to treat CA patients remotely)
• Telehealth parity: AB 744 requires equal pay for virtual psychiatric care

Texas

• NPs need physician delegation with no path to independence
• Schedule II restriction for NPs: Can only prescribe in hospital/hospice settings (limits ADHD treatment flexibility)
• Chronic pain exception: Can’t treat chronic pain via telemedicine with controlled substances, but anxiety treatment is permitted
• Part of IMLC (easier multi-state licensing for psychiatrists)
• No state payment parity for telehealth (but many insurers pay equally anyway)

Florida

• Psychiatric NPs exempt from 7-day limit on controlled substance prescriptions when treating mental health conditions
• Telehealth carve-out: Can prescribe Schedule II via telemedicine specifically for psychiatric disorders
• Out-of-state telehealth registration available, but registrants can’t prescribe controlled substances (need full FL license for that)
• PDMP mandatory: Must check E-FORCSE before prescribing any controlled anxiolytic

New York

• Full practice authority for NPs as of 2022—no collaborative agreement needed
• Strictest PDMP in the nation: Must check iSTOP database for every controlled substance prescription
• Telehealth parity: Insurers must cover tele-mental health equivalently
• Strong provider workforce (psychiatrist ratio ~1:2,900, among the best nationally)

Pennsylvania

• Restricted NP practice: Mandatory collaborative agreement with no path to independence
• Chart review requirements: Physician must countersign percentage of charts (up to 100% for Schedule II)
• No comprehensive state telehealth law, but practice follows federal rules and is generally permitted
• Medicaid and many private insurers reimburse telehealth equally

Illinois

• Earn full practice authority after 4,000 hours + 250 CE hours
• Controlled substance attestation: Even with FPA, need physician sign-off to prescribe benzos or Schedule II (one-time)
• Strong telehealth parity law (2021) for insurance coverage
• Moderate provider shortages downstate (overall ratio ~1:5,850)

Why Join a Telehealth Platform vs Building Your Own Practice?

Build your own if:

• You have 6-12 months and $30,000-60,000+ to invest in marketing before seeing consistent patient flow
• You have marketing expertise or can afford a high-quality agency
• You want full control over branding, pricing, and patient experience
• You’re in a state with minimal NP restrictions (if you’re a PMHNP)

Join a platform like Klarity if:

• You want patients immediately without upfront marketing risk
• You prefer predictable economics (pay per appointment vs gambling on marketing channels)
• You value built-in infrastructure (EHR, billing, video platform, patient matching)
• You’re scaling across multiple states and don’t want to manage 50 different marketing campaigns
• You want both insurance and cash-pay patient flow without contracting with 20+ payers yourself

The platform model isn’t about ‘giving up money’—it’s about removing patient acquisition risk. Instead of spending thousands hoping to maybe get patients eventually, you pay a transparent per-appointment fee for guaranteed qualified leads.

FAQ: Telehealth Anxiety Prescribing

Can psychiatrists prescribe Xanax via telehealth?
Yes. As of 2026, psychiatrists can prescribe benzodiazepines (Schedule IV) including Xanax, Ativan, and Klonopin through video visits without an in-person exam, thanks to extended federal telemedicine flexibilities running through December 2026. State PDMP checks are required.

Can PMHNPs prescribe anxiety medications independently?
It depends on your state. In Full Practice Authority states (like New York, Oregon, Washington), PMHNPs can prescribe all anxiety medications including controlled substances independently. In states requiring collaborative agreements (Texas, Pennsylvania, Florida), you need a supervising physician’s approval and ongoing oversight.

Do I need to see Medicare patients in-person for telehealth mental health services?
Not currently. The Medicare in-person visit requirement for tele-mental health has been repeatedly delayed and is not being enforced through at least 2026. You can continue providing telehealth anxiety management to Medicare beneficiaries without periodic in-person visits for now.

How much do telehealth platforms charge per patient?
Models vary. Klarity and similar platforms typically use a per-appointment or per-new-patient fee structure (comparable to directory booking fees of $35-100+ per lead, though exact amounts vary by platform and provider type). The key advantage: you only pay when patients actually book, vs thousands per month in uncertain marketing spend.

Can I prescribe Schedule II stimulants via telehealth for anxiety patients with ADHD?
Yes, under current federal rules through 2026. However, some states restrict NP prescribing of Schedule II drugs—Texas NPs can only prescribe Schedule II in hospital/hospice settings; Florida has a 7-day limit for non-psychiatric NPs. Psychiatrists have no such restrictions.

What’s the real cost of acquiring a psychiatric patient through DIY marketing?
Realistically $200-500+ when you factor in all costs: agency fees, ad spend, staff time for lead qualification, no-shows from cold leads, and months of SEO investment. Platforms eliminate this upfront uncertainty with transparent per-appointment fees.

Do I need a separate state license to prescribe anxiety meds via telehealth?
Yes. You must be licensed in the state where your patient is physically located during the telehealth visit. Some states participate in compacts (IMLC for physicians in some states) that streamline multi-state licensing. Others offer telehealth-specific registrations with limitations (like Florida’s out-of-state registration that prohibits controlled substance prescribing).

The Bottom Line for Providers

If you’re a psychiatrist, your telehealth prescribing authority for anxiety is essentially unlimited—you can manage the full medication spectrum across state lines (where licensed) with minimal restrictions beyond standard PDMP checks and documentation.

If you’re a PMHNP, your authority depends heavily on your state’s scope-of-practice laws. In FPA states, you’re on equal footing with psychiatrists. In restricted states, you’ll need physician collaboration, which affects both what you can prescribe and how easily you can participate in telehealth platforms.

The economics favor platforms for most providers: instead of gambling thousands on marketing with uncertain ROI, you pay per appointment and get immediate access to pre-qualified patients. That’s especially valuable given anxiety’s high prevalence and the ongoing national shortage of psychiatric prescribers.

Want to start seeing anxiety patients via telehealth without the marketing risk? Klarity Health connects psychiatrists and PMHNPs with patients who actually need medication management—no upfront spend, no wasted ad dollars, just pay-per-appointment economics that guarantee ROI. Explore the platform and see how the model works for providers in your state.

References

1. HHS Press Release – ‘HHS & DEA Extend Telemedicine Flexibilities through 2026’ (hhs.gov), January 2, 2026. Official government source on federal telehealth prescribing policy extension.

2. Florida Statutes §464.012 and §456.47 – Nurse Practice Act & Telehealth (flsenate.gov), 2024 Statutes. State law defining NP scope and telehealth prescribing rules including psychiatric exemptions.

3. California Board of Registered Nursing – AB 890 Implementation FAQs (rn.ca.gov), Updated 2024. State regulatory guidance on 103 NP and 104 NP independent practice categories.

4. NPNY Announcement – ‘NP Modernization Act Passes in NY’ (npny.enpnetwork.com), April 9, 2022. Professional association documentation of New York’s full practice authority implementation.

5. TheraThink – ‘Insurance Reimbursement Rates for Psychiatrists [2026]’ (therathink.com), 2025. Industry analysis aggregating CMS Medicare fee schedule data for psychiatric billing codes.

Source:

• https://medx.it.com/yes-a-nurse-practitioner-can-prescribe-anxiety-meds-understanding-prescribing-authority#:~:text=Nurse%20practitioners%20,three%20categories%20of%20practice%20authority
• https://www.nursepractitionerlicense.com/nurse-practitioner-licensing-guides/limitations-of-practice-as-a-nurse-practitioner-in-illinois/#:~:text=Illinois%20is%20one%20of%20the,that%20they%20can%20handle%20unsupervised
• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20and,19%20pandemic%20and
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=2025
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=The%20telemedicine%20flexibilities%20were%20first,off%20access%20to%20needed%20medications
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=The%20extension%20gives%20DEA%20and,patient%20safety%20and%20preventing%20misuse
• https://www.flsenate.gov/laws/statutes/2022/456.47#:~:text=,is%20prescribed%20for%20the%20following
• https://www.littlehealthlawblog.com/texas-state-telemedicine-prescribing-rules/#:~:text=C
• https://medx.it.com/yes-a-nurse-practitioner-can-prescribe-anxiety-meds-understanding-prescribing-authority#:~:text=While%20any%20NP%20with%20prescriptive,Their%20expertise%20includes
• https://npny.enpnetwork.com/nurse-practitioner-news/216175-breaking-news-np-modernization-act-passes#:~:text=On%20April%209th%2C%20Governor%20Hochul,Practice%20Authority%20for%20NYS%20NPs